COTA and Sanofi collaborate to accelerate cancer trials using real-world data and AI – The Cancer Letter
COTA, a leader in real-world data and analytics for oncology, is entering a collaboration with Sanofi to use RWD and artificial intelligence to increase the speed of oncology trials, including for multiple myeloma. To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? Our IP Login system is now automatic. […]